The test will probe blood samples for antibodies that show whether a person has been infected by the new coronavirus, the Basel, Switzerland-based company said in statement. Monthly production could reach the high double-digit millions by June.
“We will have a very, very steep ramp up,” said
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.